Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid function and therapeutic efficacy of thyroxine in depression.

Y Okuno1, N Nakayasu

  • 1Hara Hospital, Department of Neuropsychiatry, Gunma University School of Medicine, Maebashi, Japan.

The Japanese Journal of Psychiatry and Neurology
|December 1, 1988
PubMed
Summary

Thyroxine (T4) treatment showed antidepressant effects in patients with major depressive disorder, with higher pre-treatment thyroid function correlating with greater improvement. This suggests thyroid hormone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutations in SAM syndrome and palmoplantar keratoderma patients suggest genotype/phenotype correlations in DSG1 mutations.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

A novel orexin antagonist from a natural plant was discovered using zebrafish behavioural analysis.

European review for medical and pharmacological sciences·2020
Same author

Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.

Diabetes & metabolism·2019
Same author

Sterol profiles are valuable biomarkers for phenotype expression of Conradi-Hünermann-Happle syndrome with EBP mutations.

The British journal of dermatology·2018
Same author

A novel IFIH1 mutation in the pincer domain underlies the clinical features of both Aicardi-Goutières and Singleton-Merten syndromes in a single patient.

The British journal of dermatology·2017
Same author

Trichothiodystrophy, complementation group A complicated with squamous cell carcinoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Area of Science:

  • Endocrinology
  • Psychiatry
  • Neuroscience

Background:

  • Major depressive disorder (MDD) is a prevalent mental health condition.
  • Thyroid hormones play a crucial role in regulating mood and cognitive functions.
  • Previous research suggests a link between thyroid dysfunction and depression.

Purpose of the Study:

  • To investigate the efficacy of thyroxine (T4) monotherapy in treating primary major depressive disorders.
  • To explore the relationship between baseline thyroid function and the antidepressant response to T4.

Main Methods:

  • Administered 50-100 micrograms of thyroxine (T4) daily for 2 weeks to 20 patients with MDD.
  • Evaluated clinical changes using the Hamilton Rating Scale (HAM-D).
  • Assessed thyroid function (T3, T4, T3 uptake, free T4 index, BMR) before and after treatment.

Related Experiment Videos

Main Results:

  • Significant decrease in HAM-D scores observed, indicating antidepressant efficacy of T4 monotherapy.
  • Antidepressive effects varied widely among patients.
  • Clinical improvement positively correlated with pre-trial levels of T3, T4, T3 uptake, free T4 index, and basal metabolic rate (BMR).

Conclusions:

  • Thyroxine (T4) monotherapy demonstrates efficacy in treating major depressive disorder.
  • Higher baseline thyroid function is associated with a greater antidepressant response to T4.
  • The antidepressive effects of T4 may involve the suppression of endogenous thyroid hormones.